data

Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from Multiple Phase 1/2 Gene Therapy Studies

Durable and Clinically Meaningful Responses Reported from Phase 1/2 Studies of DTX401 for GSDIa and DTX301 for OTC

Phase 3 Studies for DTX401 and DTX301 to Begin in 2021

IND for UX701 for Wilson Disease Submitted; Expect to Enter Clinic in First Half 2021 using AAV Drug Product Made by HeLa PCL Platform

NOVATO, Calif. , Jan. 08, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced positive longer-term safety and efficacy data from the first three cohorts of the ongoing Phase 1/2 studies of DTX401, an investigational adeno-associated virus (AAV) gene therapy for Glycogen Storage Disease Type Ia (GSDIa), and DTX301, an AAV gene therapy for ornithine transcarbamylase (OTC) deficiency. In addition, dosing is nearing completion for the prophylactic steroid cohorts in both studies. Discussions with regulatory agencies continue to

Haptic Technology Market 2021 : Business Opportunities, Current Trends, Challenges & Global Industry Analysis by 2026 with Top Countries Data

The MarketWatch News Department was not involved in the creation of this content.

Dec 11, 2020 (The Expresswire) —
Haptic Technology Market Research Report 2020-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical and futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Haptic Technology Market study provides comprehensive data that enhances the understanding, scope, and application of this report. The Report Contain 90 Pages With Detailed Analysis.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Final Report will add the analysis of the impact of COVID-19 on this industry.

TO UNDERSTAND HOW COVID-19 IMPACT

5G Market Analysis Investigation Growth by Top Companies, consumption by Regional data, Trends by Types and Application, Forecast Analysis to 2024

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (The Expresswire) —
5G Market provides detailed analysis of Market Overview, Drivers, Prospects, Potential Application. Also 5G Industry research report includes the future impact of major drivers and challenges and, support decision makers in manufacture cost-effective professional decisions. 5G networks are the next generation of mobile internet connectivity, offering faster speeds and more reliable connections on smartphones and other devices than ever before. It moreover discussions about the 5G market size of different sections and their growth aspects along with growth trends, various investors, business leader, dealers, sellers, Study and media,SWOT analysis.

2020 5G Market Report Contains:-

● Complete overview of the global 5G Market ● Top Country data and analysis for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc.